Company intelligence / Profile preview
Lacorium Health
Copenhagen, Denmarklacorium.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Lacorium Health is a biotechnology company developing engineered live biotherapeutic products (LBPs) for the treatment of inflammatory bowel diseases. The company's platform utilizes engineered Lactobacillus strains to deliver therapeutic proteins directly to the gastrointestinal mucosa, aiming to provide high local concentrations of medicine while reducing systemic exposure. This approach seeks to improve the safety and efficacy profile of biologics used in treating conditions like Ulcerative Colitis. Lacorium was spun out of the Technical University of Denmark and is supported by the BioInnovation Institute.
- Therapeutic areas
- Gastroenterology
- Modalities
- Live biotherapeutic product therapyMicrobial therapyProtein
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
BioInnovation Institute
Beyond the preview
Go deeper on Lacorium Health.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lacorium Health.